Prostaglandin E2: from clinical applications to its potential role in bone- muscle crosstalk and myogenic differentiation.
about
Store-operated Ca2+ entry in muscle physiology and diseasesBone and muscle: Interactions beyond mechanical.METTL21C is a potential pleiotropic gene for osteoporosis and sarcopenia acting through the modulation of the NF-κB signaling pathway.Skeletal muscle Ca(2+) mishandling: Another effect of bone-to-muscle signaling.Interdependence of muscle atrophy and bone loss induced by mechanical unloadingProstaglandin E2 is essential for efficacious skeletal muscle stem-cell function, augmenting regeneration and strengthForum on bone and skeletal muscle interactions: summary of the proceedings of an ASBMR workshop.Imaging and quantifying solute transport across periosteum: implications for muscle-bone crosstalk.Lower Serum Creatinine Is Associated with Low Bone Mineral Density in Subjects without Overt NephropathyCellular and Physiological Effects of Dietary Supplementation with β-Hydroxy-β-Methylbutyrate (HMB) and β-Alanine in Late Middle-Aged Mice.Prostaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation.Inhibition of COX1/2 alters the host response and reduces ECM scaffold mediated constructive tissue remodeling in a rodent model of skeletal muscle injuryDeletion of Mbtps1 (Pcsk8, S1p, Ski-1) Gene in Osteocytes Stimulates Soleus Muscle Regeneration and Increased Size and Contractile Force with Age.The central nervous system (CNS)-independent anti-bone-resorptive activity of muscle contraction and the underlying molecular and cellular signatures.Skeletal Muscle, but not Cardiovascular Function, Is Altered in a Mouse Model of Autosomal Recessive Hypophosphatemic Rickets.Bone and skeletal muscle: neighbors with close tiesThe Association between Muscle Mass Deficits Estimated from Bioelectrical Impedance Analysis and Lumbar Spine Bone Mineral Density in Korean AdultsThe osteocyte: an endocrine cell ... and more.A dual mode pulsed electro-magnetic cell stimulator produces acceleration of myogenic differentiation.Changes in thigh muscle volume predict bone mineral density response to lifestyle therapy in frail, obese older adultsInteraction between Muscle and Bone.Muscle-bone interactions: basic and clinical aspects.The skeletal muscle arachidonic acid cascade in health and inflammatory disease.Targeted quantification of lipid mediators in skeletal muscles using restricted access media-based trap-and-elute liquid chromatography-mass spectrometry.Osteocyte secreted factors inhibit skeletal muscle differentiation.Relaxin and insulin-like peptide 3 in the musculoskeletal system: from bench to bedside.The Role of the Osteocyte in Bone and Nonbone Disease.The Role of TGFβ in Bone-Muscle Crosstalk.Mechanical basis of bone strength: influence of bone material, bone structure and muscle actionThe parathyroid hormone-regulated transcriptome in osteocytes: parallel actions with 1,25-dihydroxyvitamin D3 to oppose gene expression changes during differentiation and to promote mature cell function.Gender-specific pleiotropic bone-muscle relationship in the elderly from a nationwide survey (KNHANES IV).Regulatory gene networks that shape the development of adaptive phenotypic plasticity in a cichlid fish.Childhood cortical porosity is related to microstructural properties of the bone-muscle junction.Association between pre-sarcopenia, sarcopenia, and bone mineral density in patients with chronic hepatitis C.The Role of Bone Secreted Factors in Burn-Induced Muscle Cachexia.β-aminoisobutyric Acid, l-BAIBA, Is a Muscle-Derived Osteocyte Survival Factor.Evaluation of serum myostatin and sclerostin levels in chronic spinal cord injured patients.Muscle-Bone Crosstalk: Emerging Opportunities for Novel Therapeutic Approaches to Treat Musculoskeletal Pathologies.Protective Role of Testicular Hormone INSL3 From Atrophy and Weakness in Skeletal Muscle
P2860
Q27026415-0B0CFA3B-1CD9-4E01-9154-5DF8E1AD9FDFQ28606563-41EC99DF-AF33-4D12-A58E-1F37AFE049A4Q30973924-56955C1A-A347-4808-8B8A-A827635B33FDQ33602302-8DF67E75-5E69-445C-9EBC-02EF83801CEFQ33820690-692D2635-4FAC-4A94-9C91-61977E3FF88EQ33865658-EDA46178-8125-4201-B7E1-A32E6ADF5CC9Q34344489-043CDAC4-1C6A-4445-8E97-D391030DE991Q35188081-684DB72B-E091-4948-83E9-B4405AE33CC4Q35710756-D5A09C4C-260B-410C-BDB1-2EA15486C8FBQ35948968-830549E3-8AFA-4563-BD2B-44ABCA660436Q36189498-C73874BC-F16F-43CC-B2BA-546FE1CA452BQ36507709-1718A11D-A8CC-413A-B45D-A9C8CA45E6F2Q36744463-DA8DFD8A-55F0-4CD6-AB42-A19BDC88BA90Q36832631-1F6A7102-3279-40D6-9420-2D13F7B44C25Q36899883-64A99EE2-AE6F-4270-9EF0-504234DE43B2Q36968228-3B0ED536-E1D4-4651-976E-62ECAC03835FQ36989643-C3441FBC-2285-4487-B224-42ADE4BE6529Q37203605-26CE1127-905F-4912-AC64-D93309D3DF02Q37274638-CAFEB340-1101-4FB4-AC97-4BCBE383CEF7Q37521197-BECFD7E4-4B0D-4502-A8C7-1048DEF7F42FQ37673464-1D9434D1-718D-452F-9912-A115A21B41AAQ38132696-0A6AD52F-7F0B-4595-88AB-D97A2CFBD305Q38182345-CC309D3E-D6A3-4923-AF49-A51CB332CF17Q38636997-551A16C1-0064-4DB9-A3D2-68AE188E1C73Q38734896-879BE946-D273-4FCA-ADDD-9B81651B7CFFQ38802490-EB16365A-36A9-4D56-8B79-E9776D61D57CQ39107516-97285F55-39A6-494E-8715-242C3524999BQ39120074-F3D7EE4A-56E5-43F9-AE5D-53A2D9EAA7B5Q41707116-48AA9412-A480-4CB8-8BCE-4EF884D57F19Q42002069-41E943EF-2C18-42DF-A9D8-950386129D18Q43683435-56BEE4D1-A937-4717-8257-5F25D1DDEAF9Q46177259-D6E83550-04F6-4CDA-AE15-68A1BFDC42F7Q46990217-395CAFFA-289C-4B66-8C5D-1EB58D9B0E75Q47551529-3FA16C73-8EAA-4CDA-8FF9-EC4D98CA2DE1Q49980475-B1FFAE65-2684-45FD-9CB9-CE4A42EC6E05Q50098019-42DD296C-4409-4C90-9336-567BA4728ED6Q50927799-68102864-2CD4-408E-98C9-EFFC2B862BF3Q53005827-3F62BF0B-9A03-4372-9F5A-7BABE5C1453DQ57490061-FEA21E23-C662-4AB3-AB2E-99DEDA21397E
P2860
Prostaglandin E2: from clinical applications to its potential role in bone- muscle crosstalk and myogenic differentiation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prostaglandin E2: from clinica ...... and myogenic differentiation.
@en
Prostaglandin E2: from clinica ...... and myogenic differentiation.
@nl
type
label
Prostaglandin E2: from clinica ...... and myogenic differentiation.
@en
Prostaglandin E2: from clinica ...... and myogenic differentiation.
@nl
prefLabel
Prostaglandin E2: from clinica ...... and myogenic differentiation.
@en
Prostaglandin E2: from clinica ...... and myogenic differentiation.
@nl
P2093
P2860
P1476
Prostaglandin E2: from clinica ...... and myogenic differentiation.
@en
P2093
Chenglin Mo
Lynda Bonewald
Marco Brotto
Mark Johnson
Sandra Romero-Suarez
P2860
P304
P356
10.2174/1872208311206030223
P577
2012-12-01T00:00:00Z